Clinical Trial Update: Respicardia, Inc. Pivotal Trial of the remedē System [NA]

View source ↗

Summary

Respicardia's remedē System completed a pivotal trial for central sleep apnea and related sleep-disordered breathing, with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Sleep Apnea
• Heart Failure
• Sleep-disordered Breathing

Snippet

Sponsor: Respicardia, Inc. | Conditions: Sleep Apnea, Central, Sleep Disordered Breathing | NA | Status: COMPLETED | Results posted: 2017-07-11